AUA 2022: Should everyone have adjuvant therapy after surgery for high-risk kidney cancer?
The 2022 American Urological Association (AUA) Annual Meeting included a [...]
The 2022 American Urological Association (AUA) Annual Meeting included a [...]
During the American Society of Clinical Oncology (ASCO) Annual Meeting [...]
During the American Society of Clinical Oncology Annual Meeting earlier [...]
Studies looking at the genes of people with kidney cancer [...]
Ongoing results from the phase 3 CheckMate-9ER clinical trial with [...]
At the American Society of Clinical Oncology (ASCO) Annual Meeting [...]
At the American Society of Clinical Oncology (ASCO) Annual Meeting [...]
Adjuvant therapy is medication that is given in addition to [...]
This phase 2 clinical trial (ENTRATA) looked at how safe [...]
Just over half of the patients from a phase 2 [...]